Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10006570HBVENSG00000125730.18protein_codingC3NoNo718P01024
TVIS10004926HBVENSG00000125730.18protein_codingC3NoNo718P01024
TVIS10004927HBVENSG00000125730.18protein_codingC3NoNo718P01024
TVIS10004928HBVENSG00000125730.18protein_codingC3NoNo718P01024
TVIS10017617HBVENSG00000125730.18protein_codingC3NoNo718P01024
TVIS10017933HBVENSG00000125730.18protein_codingC3NoNo718P01024
TVIS10025344HBVENSG00000125730.18protein_codingC3NoNo718P01024
TVIS10019569HBVENSG00000125730.18protein_codingC3NoNo718P01024
TVIS10019255HBVENSG00000125730.18protein_codingC3NoNo718P01024
TVIS10019037HBVENSG00000125730.18protein_codingC3NoNo718P01024
TCGA Plot Options
Drug Information
GeneC3
DrugBank IDDB00028
Drug NameHuman immunoglobulin G
Target IDBE0003455
UniProt IDP01024
Regulation Typebinder
PubMed IDs20441428; 17351760; 17911465
CitationsBaerenwaldt A, Biburger M, Nimmerjahn F: Mechanisms of action of intravenous immunoglobulins. Expert Rev Clin Immunol. 2010 May;6(3):425-34. doi: 10.1586/eci.10.9.@@Negi VS, Elluru S, Siberil S, Graff-Dubois S, Mouthon L, Kazatchkine MD, Lacroix-Desmazes S, Bayry J, Kaveri SV: Intravenous immunoglobulin: an update on the clinical use and mechanisms of action. J Clin Immunol. 2007 May;27(3):233-45. Epub 2007 Mar 11.@@Siberil S, Elluru S, Graff-Dubois S, Negi VS, Delignat S, Mouthon L, Lacroix-Desmazes S, Kazatchkine MD, Bayry J, Kaveri SV: Intravenous immunoglobulins in autoimmune and inflammatory diseases: a mechanistic perspective. Ann N Y Acad Sci. 2007 Sep;1110:497-506.
GroupsApproved; Investigational
Direct ClassificationPeptides
SMILES
Pathways
PharmGKBPA164754884
ChEMBL